Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Zepbound contains tirzepatide, a newer dual GLP-1/GIP receptor agonist that works on two metabolic hormone pathways simultaneously, producing even greater average weight loss compared to semaglutide alone
These include: Those with a History of Thyroid Cancer People with a personal or family history of thyroid cancer, like medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2), should avoid semaglutide due to potential risks
With more obesity medication options available along with indications for treatment of obesity-related diseases, doctors will be increasingly able to personalize treatments
This is due to the rapidly rising prevalence of diabetes and obesity across major economies
2018;103(5):1715 to 1744
